NCT02397902

Brief Summary

The specific aim of the proposed study is to address the efficacy of conventional full-fat dairy products as part of the normal routine diet for improving vascular function and reducing blood pressure in middle-aged and older adults with elevated blood pressure. The investigators hypothesize that dietary intervention including whole milk and full-fat milk products will induce significant decreases in systolic blood pressure and arterial stiffness. The investigators also test the hypothesis that the reductions in blood pressure will be associated with the corresponding decreases in arterial stiffness and/or increases in endothelial vasodilatory function as well as improvements in arterial baroreflex sensitivity. If our hypotheses are supported by the results, the information could be used as a basis for recommendations for the use of whole milk and full-fat milk products in the secondary prevention of elevated blood pressure and vascular dysfunction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Mar 2015

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 16, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 25, 2015

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2018

Completed
Last Updated

February 1, 2018

Status Verified

January 1, 2018

Enrollment Period

2.9 years

First QC Date

March 16, 2015

Last Update Submit

January 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Seated blood pressure

    4 weeks

Secondary Outcomes (4)

  • 24-hour ambulatory blood pressure

    4 weeks

  • Carotid arterial compliance as measured by arterial pressure and corresponding cross-sectional area by ultrasound

    4 weeks

  • Arterial stiffness as measured by pulse wave velocity between the aortic arch and femoral artery

    4 weeks

  • Flow mediated dilation

    4 weeks

Study Arms (2)

Dairy

EXPERIMENTAL

Add 4 daily servings of high fat dairy to diet for a period of 4 weeks

Dietary Supplement: High fat dairy

Plant-based

ACTIVE COMPARATOR

Add 4 daily servings of fruit to diet and/or plant-based milk, remove all dairy from diet for a period of 4 weeks

Dietary Supplement: Plant-based

Interventions

High fat dairyDIETARY_SUPPLEMENT

Add 4 daily servings per day of high fat dairy (yogurt, milk, cheese) for a period of 4 weeks

Dairy
Plant-basedDIETARY_SUPPLEMENT

Add 4 daily servings of fruit (fruit cup, apple sauce) and/or plant-based milk, remove all dairy for a period for 4 weeks

Plant-based

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prehypertension or stage-1 hypertension

You may not qualify if:

  • Consume \> 3 servings of dairy or fruit per day
  • Strenuous physical activity \> 3 time per week
  • Lactose intolerance, pregnancy, lactation, and/or alcohol abuse
  • Taking cardiovascular-acting drugs
  • Overt cardiovascular disease, metabolic disease, GI disorders and/or renal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

HypertensionPrehypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Tanaka Hirofumi, PhD

    The University of Texas at Austin

    PRINCIPAL INVESTIGATOR
  • Stephen J Roy, MS

    The University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 16, 2015

First Posted

March 25, 2015

Study Start

March 1, 2015

Primary Completion

January 30, 2018

Study Completion

January 30, 2018

Last Updated

February 1, 2018

Record last verified: 2018-01

Locations